CVE-2026-10303 - ServerCo getssl ACME shell script path injection
CVE ID :CVE-2026-10303
Published : June 16, 2026, 8:16 p.m. | 1 hour, 22 minutes ago
Description :In ServerCo getssl version 2.49 and prior, the ACME challenge token returned to the client was not strictly validated against RFC 8555 before being used in challenge-file handling, allowing a maliciously crafted token to influence local path/filename usage during validation. An attacker who can supply ACME challenge responses to getssl (for example, a malicious or compromised CA endpoint, or an on-path adversary able to tamper with that response path) could exploit this to achieve unauthorized file write/path traversal effects, usually with elevated privileges, ultimately allowing for remote command injection. This issue appears related in spirit to CVE-2023-38198, and is an instance of CWE-73, "External control of file name or path." Other ACME shell script handlers may be affected by similar issues.
Severity: 7.4 | HIGH
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : June 16, 2026, 8:16 p.m. | 1 hour, 22 minutes ago
Description :In ServerCo getssl version 2.49 and prior, the ACME challenge token returned to the client was not strictly validated against RFC 8555 before being used in challenge-file handling, allowing a maliciously crafted token to influence local path/filename usage during validation. An attacker who can supply ACME challenge responses to getssl (for example, a malicious or compromised CA endpoint, or an on-path adversary able to tamper with that response path) could exploit this to achieve unauthorized file write/path traversal effects, usually with elevated privileges, ultimately allowing for remote command injection. This issue appears related in spirit to CVE-2023-38198, and is an instance of CWE-73, "External control of file name or path." Other ACME shell script handlers may be affected by similar issues.
Severity: 7.4 | HIGH
Visit the link for more details, such as CVSS details, affected products, timeline, and more...